Thomas A. West - Jul 23, 2021 Form 4 Insider Report for Intersect ENT, Inc. (XENT)

Role
President and CEO, Director
Signature
/s/ Patrick A. Broderick, Attorney-in-Fact for Thomas A. West
Stock symbol
XENT
Transactions as of
Jul 23, 2021
Transactions value $
-$420,717
Form type
4
Date filed
7/27/2021, 05:05 PM
Next filing
Dec 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XENT Common Stock Tax liability -$380K -19.2K -6.91% $19.74 259K Jul 23, 2021 Direct F1, F2, F3
transaction XENT Common Stock Tax liability -$40.8K -2.01K -0.78% $20.29 257K Jul 23, 2021 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares tendered in payment of the tax withholding obligation in compliance and as required by the company's equity documents.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.12 to $20.10, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3 Includes 500 shares purchased on 5/14/2021 with ESPP plan and 174,819 restricted stock units, of which 39,700 are performance based.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.12 to $20.44, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.